These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16791470)

  • 1. Proteomic identification of a two-component regulatory system in Pseudoalteromonas haloplanktis TAC125.
    Papa R; Glagla S; Danchin A; Schweder T; Marino G; Duilio A
    Extremophiles; 2006 Dec; 10(6):483-91. PubMed ID: 16791470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the transcription factor responsible for L-malate-dependent regulation in the marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Papa R; Rippa V; Duilio A
    FEMS Microbiol Lett; 2009 Jun; 295(2):177-86. PubMed ID: 19646180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated recombinant protein production in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Rippa V; Papa R; Giuliani M; Pezzella C; Parrilli E; Tutino ML; Marino G; Duilio A
    Methods Mol Biol; 2012; 824():203-18. PubMed ID: 22160900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cold-active Lip1 lipase from the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 is a member of a new bacterial lipolytic enzyme family.
    de Pascale D; Cusano AM; Autore F; Parrilli E; di Prisco G; Marino G; Tutino ML
    Extremophiles; 2008 May; 12(3):311-23. PubMed ID: 18437283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life in the cold: a proteomic study of cold-repressed proteins in the antarctic bacterium pseudoalteromonas haloplanktis TAC125.
    Piette F; D'Amico S; Mazzucchelli G; Danchin A; Leprince P; Feller G
    Appl Environ Microbiol; 2011 Jun; 77(11):3881-3. PubMed ID: 21478318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel synthetic medium and expression system for subzero growth and recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
    Sannino F; Giuliani M; Salvatore U; Apuzzo GA; de Pascale D; Fani R; Fondi M; Marino G; Tutino ML; Parrilli E
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):725-734. PubMed ID: 27796433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-scale metabolic reconstruction and constraint-based modelling of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Fondi M; Maida I; Perrin E; Mellera A; Mocali S; Parrilli E; Tutino ML; Liò P; Fani R
    Environ Microbiol; 2015 Mar; 17(3):751-66. PubMed ID: 24889559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic and periplasmic proteomic signatures of exponentially growing cells of the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC125.
    Wilmes B; Kock H; Glagla S; Albrecht D; Voigt B; Markert S; Gardebrecht A; Bode R; Danchin A; Feller G; Hecker M; Schweder T
    Appl Environ Microbiol; 2011 Feb; 77(4):1276-83. PubMed ID: 21183643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective cold inducible expression system developed in Pseudoalteromonas haloplanktis TAC125.
    Papa R; Rippa V; Sannia G; Marino G; Duilio A
    J Biotechnol; 2007 Jan; 127(2):199-210. PubMed ID: 16959351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
    Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
    N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoters from a cold-adapted bacterium: definition of a consensus motif and molecular characterization of UP regulative elements.
    Duilio A; Madonna S; Tutino ML; Pirozzi M; Sannia G; Marino G
    Extremophiles; 2004 Apr; 8(2):125-32. PubMed ID: 15064979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125: a promising micro-organism for the bioremediation of aromatic compounds.
    Papa R; Parrilli E; Sannia G
    J Appl Microbiol; 2009 Jan; 106(1):49-56. PubMed ID: 19120609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The globins of cold-adapted Pseudoalteromonas haloplanktis TAC125: from the structure to the physiological functions.
    Giordano D; Coppola D; Russo R; Tinajero-Trejo M; di Prisco G; Lauro F; Ascenzi P; Verde C
    Adv Microb Physiol; 2013; 63():329-89. PubMed ID: 24054800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The truncated hemoglobins in the Antarctic psychrophilic bacterium Pseudoalteromonas haloplanktis TAC125.
    Giordano D; Parrilli E; Dettaï A; Russo R; Barbiero G; Marino G; Lecointre G; di Prisco G; Tutino L; Verde C
    Gene; 2007 Aug; 398(1-2):69-77. PubMed ID: 17582708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Colarusso A; Lauro C; Calvanese M; Parrilli E; Tutino ML
    Microb Cell Fact; 2022 Oct; 21(1):211. PubMed ID: 36242022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel strategy for the construction of genomic mutants of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Giuliani M; Parrilli E; Pezzella C; Rippa V; Duilio A; Marino G; Tutino ML
    Methods Mol Biol; 2012; 824():219-33. PubMed ID: 22160901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of multiple globin genes conferring protection against nitrosative stress to the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Coppola D; Giordano D; Milazzo L; Howes BD; Ascenzi P; di Prisco G; Smulevich G; Poole RK; Verde C
    Nitric Oxide; 2018 Feb; 73():39-51. PubMed ID: 29275194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling microbial metabolic rewiring during growth in a complex medium.
    Fondi M; Bosi E; Presta L; Natoli D; Fani R
    BMC Genomics; 2016 Nov; 17(1):970. PubMed ID: 27881075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale biofilm cultivation of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 for physiologic studies and drug discovery.
    Parrilli E; Ricciardelli A; Casillo A; Sannino F; Papa R; Tilotta M; Artini M; Selan L; Corsaro MM; Tutino ML
    Extremophiles; 2016 Mar; 20(2):227-34. PubMed ID: 26847199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular adaptations in Antarctic fish and marine microorganisms.
    Giordano D; Russo R; di Prisco G; Verde C
    Mar Genomics; 2012 Jun; 6():1-6. PubMed ID: 22578653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.